Congressional Investigations

Chambers-ranked, politically savvy, and deeply experienced at protecting your interests when Congress investigates your company/institution.

Subscribe to our latest insights.

Our decades-old congressional investigations practice has assisted dozens of clients facing both voluntary and involuntary inquiries from Congress. We routinely represent major life science companies, leading research universities, financial services companies, manufacturers, and other high profile individuals and entities facing a congressional inquiry. Our team helps clients respond to written questions; prepare for voluntary transcribed interviews, depositions under subpoena, and public hearings (“murder boards”); prepare and produce documents required by Congress; and develop congressional testimony.

We understand that, for many publicly-traded companies, the handling of an inquiry from Congress can be a market-moving event. We understand that producing confidential and proprietary information can have major ramifications for your bottom line. We also understand that Members of Congress and their staff have a job to do—and that, often, compromise is possible. We do everything possible to negotiate reasonable accommodations designed to protect your interests.

We are committed to providing our clients with the highest level of personalized service and attention. We understand that congressional investigations can be stressful and an uncertain experience, and we understand how jarring it is to receive a letter from a Member of Congress. We are dedicated to guiding our clients through every step of the process with empathy, expertise, and a relentless focus on achieving the best possible outcome.

We put our people with investigations experience gained on Capitol Hill in the lead, dealing directly with investigative committees. They are backed by regulatory and investigations colleagues, together with a high-powered lobbying team. We feature two former U.S. Senators, who understand what current lawmakers are thinking and are adept at helping clients “tell their story.” This integrated team sets us apart from competitors.

In recent years, we have represented numerous clients before several House and Senate committees, including:

Senate Committee on Commerce, Science, and Transportation
Senate Committee on Finance
Senate Committee on Health, Education, Labor, and Pensions
Senate Committee on Homeland Security and Governmental Affairs/Permanent Subcommittee on Investigations
Senate Committee on the Judiciary
Senate Committee on the Budget
House Committee on Education and the Workforce
House Committee on Energy and Commerce
House Committee on Financial Services
House Committee on the Judiciary
House Committee on Oversight and Government Reform
House Committee on Ways and Means
House Select Committee on China

Key contacts

Aaron Cutler

Partner

Aaron Cutler

Partner

Washington, D.C.

Senator Norm Coleman

Senior Counsel

Senator Norm Coleman

Senior Counsel

Washington, D.C., Minneapolis

Michael J. Bell

Partner

Michael J. Bell

Partner

Washington, D.C.

Ari Fridman

Partner

Ari Fridman

Partner

Washington, D.C.

Ivan Zapien

Partner

Ivan Zapien

Partner

Washington, D.C.

Meet the Congressional Investigations team

Representative experience

Representing a major manufacturer of household & consumer products in an investigation before the House Judiciary Committee on issues involving free speech and communications with consumers.

Representing a food producer in an investigation involving members of the House and Senate, multiple Congressional Committees, and federal agencies into food safety issues.

Representing a major pharmaceutical manufacturer in an investigation before multiple committees in both the House and Senate regarding drug pricing agreements.

Represented a major automaker in an investigation before the House Ways and Means Committee into issues involving tax credits for electric vehicles and their impact on supply chain decisions.

Representing an organ procurement organization (“OPO”) in an inquiry into allegations of federal and state law violations before the House Ways and Means Committee, preparing multiple employees for transcribed interviews.

Representing a major proxy service advisory company in a years-long antitrust inquiry conducted by the House Committee on the Judiciary.

Representing a major health insurance company in an inquiry by the House Committee on the Judiciary into alleged fraud with respect to Affordable Care Act tax credits.

Representing an Ivy League university in an inquiry before the House Committee on the Judiciary into alleged antitrust violations in setting tuition pricing.

Representing an auto manufacturer before the House Ways and Means Committee into concerns surrounding the use of EV tax credits.

Represented a U.S. airline in an investigation before the Senate’s Permanent Subcommittee on Investigations into airlines fees, including responding to inquiries and document requests, and preparation for a Committee hearing.

Represented a major university before the House Energy and Commerce Committee with respect to the campus’s handling of complaints of antisemitism from students and faculty.

Represented a preeminent trade association before the House Select Committee on the Chinese Communist Party with respect to U.S.-China trade policy.

Represented OPOs before the Senate Finance Committee with respect to inquiries over alleged conflicts of interest and record keeping practices, as well as before a House Subcommittee investigating alleged waste, fraud, and abuse within the organ-donor community.

Advised a major scientific research organization in responding to an inquiry before the House Select Subcommittee on the Coronavirus Pandemic.

Represented several automobile manufacturers and major parts suppliers in an investigation by the Senate Finance Committee into the global automotive supply chain.

Assisted one of the world’s largest insurance companies in responding to a request from the Senate Budget Committee for information regarding the impact of climate change on the insurance industry.

Represented a major technology company in responding to a detailed Senate Finance Committee inquiry related to foreign tax structuring, including responding to Committee questions and interviews.

Represented a live entertainment company during a congressional inquiry concerning ticket pricing, including preparing the company’s CEO to testify before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations.

Represented a major health insurer during investigations by three Senate and two House Committees, including testimony by the company’s CEO and several other high-level executives, and follow-on inquiries by state attorneys general, state legislatures, and a federal agency.

Represented a major drug manufacturer through all phases of a Congressional investigation, including responding to inquiries and document requests, drafting of testimony and preparing the CEO to testify before two Congressional committees.